FDA Adverse Event Injury Summary report: N

BIPAP A40 PRO

MDR report key: 24315412 · Received February 11, 2026

Report

Report Number
2518422-2026-100912
Event Type
Injury
Date Received
February 11, 2026
Date of Event
April 28, 2023
Report Date
February 11, 2026
Manufacturer
RESPIRONICS, INC.
Product Code
MNT
UDI-DI
00606959055063
PMA / PMN Number
K121623
Removal / Correction Number
Z-1813-2024
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
UK
Reporter Occupation
003

Narratives

Additional Manufacturer Narrative · 0

THE BIPAP A40 PRO IS SUBSTANTIALLY SIMILAR TO THE BIPAP A40AND WILL BE REPORTED IN THE UNITED STATES UNDER BIPAP A40, 501K NUMBER: K121623.

Description of Event or Problem · 0

THE MANUFACTURER RECEIVED INFORMATION ALLEGING PATIENT WAS HOSPITALIZED. THE DEVICE HAS NOT YET BEEN RETURNED TO THE MANUFACTURER FOR EVALUATION. IF ANY ADDITIONAL INFORMATION IS RECEIVED, A FOLLOW-UP REPORT WILL BE FILED. PRIOR TO IDENTIFYING THE ISSUE DESCRIBED IN FSN 2023-CC-SRC-039, COMPLAINTS ASSOCIATED WITH THE ISSUE DID NOT MEET REQUIREMENTS FOR VIGILANCE REPORTING AS A REPORTABLE INCIDENT. AS PART OF THE HHE PROCESS, A RETROSPECTIVE REVIEW OF COMPLAINTS ASSOCIATED WITH THE ISSUE DESCRIBED IN FSN 2023-CC-SRC-039 WAS NECESSARY TO REASSESS REPORTABILITY. UPON THIS FURTHER ASSESSMENT, THESE COMPLAINTS ARE BEING REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
373867 BIPAP A40 PRO VENTILATOR, CONTINUOUS, MINIMAL VENTILATORY SUPPORT, FACILITY USE MNT RESPIRONICS, INC. GBX3100S19 00606959055063

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown Hospitalization